Biomarkers to prevent disability in multiple sclerosis

Kalincik, Tomas (Primary Chief Investigator (PCI))
Havrdova, Eva Kubala (Chief Investigator (CI))
Kuhle, Jens (Chief Investigator (CI))
Olsson, Tomas (Chief Investigator (CI))
Hillert, Jan (Chief Investigator (CI))
Taylor, Bruce V. (Chief Investigator (CI))
Malpas, Charles (Chief Investigator (CI))
Kilpatrick, Trevor John (Chief Investigator (CI))
Barnett, Michael Harry (Chief Investigator (CI))
Buzzard, Katherine (Associate Investigator (AI))

Project: Research

Status	Finished
Effective start/end date	1/07/19 → 30/06/22

Keywords

multiple sclerosis (MS), disease outcome, individualising management, therapy, prediction.

12 Article

Comparative effectiveness in multiple sclerosis: A methodological comparison
Roos, I., Diouf, I., Sharmin, S., Horakova, D., Havrdova, E. K., Patti, F., Shaygannejad, V., Ozakbas, S., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Girard, M., Duquette, P., Terzi, M., Boz, C., Grand’Maison, F. & Sola, P. & 52 others, Ferraro, D., Grammond, P., Turkoglu, R., Buzzard, K., Skibina, O., Yamou, B., Altintas, A., Gerlach, O., van Pesch, V., Blanco, Y., Maimone, D., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., McGuigan, C., Cartechini, E., Barnett, M., Hughes, S., Sa, M. J., Solaro, C., Ramo-Tello, C., Hodgkinson, S., Spitaleri, D., Soysal, A., Petersen, T., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Van Wijmeersch, B., van der Walt, A., Butzkueven, H., Prevost, J., Sanchez-Menoyo, J. L., Laureys, G., Gouider, R., Castillo-Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Deri, N., Al-Harbi, T., Fragoso, Y., Csepany, T., Sempere, A. P., Trevino-Frenk, I., Schepel, J., Moore, F., Malpas, C., Kalincik, T. & on behalf of the MSBase Study Group, Mar 2023, In: Multiple Sclerosis Journal. 29, 3, p. 326–332 7 p.
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Roos, I., Hughes, S., McDonnell, G., Malpas, C. B., Sharmin, S., Boz, C., Alroughani, R., Ozakbas, S., Buzzard, K., Skibina, O., van der Walt, A., Butzkueven, H., Lechner-Scott, J., Kuhle, J., Terzi, M., Laureys, G., Van Hijfte, L., John, N., Grammond, P. & Grand'Maison, F. & 18 others, Soysal, A., Jensen, A. V., Rasmussen, P. V., Svendsen, K. B., Barzinji, I., Nielsen, H. H., Sejbæk, T., Prakash, S., Stilund, M. L. M., Weglewski, A., Issa, N. M., Kant, M., Sellebjerg, F., Gray, O., Magyari, M., Kalincik, T., for the MSBase Study Group & for the Danish MS Registry Study Group, 1 Aug 2023, In: JAMA Neurology. 80, 8, p. 789-797 9 p.
Research output: Contribution to journal › Article › Research › peer-review

20 Citations (Scopus)
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study
Vitkova, M., Diouf, I., Malpas, C., Horakova, D., Kubala Havrdova, E., Patti, F., Ozakbas, S., Izquierdo, G., Eichau, S., Shaygannejad, V., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Larochelle, C., Girard, M., Duquette, P., Terzi, M., Boz, C. & Grand'maison, F. & 43 others, Sola, P., Ferraro, D., Grammond, P., Butzkueven, H., Buzzard, K., Skibina, O., Yamout, B. I., Karabudak, R., Gerlach, O., Lechner-Scott, J., Maimone, D., Bergamaschi, R., Van Pesch, V., Iuliano, G., Cartechini, E., José Sà, M., Ampapa, R., Barnett, M., Hughes, S. E., Ramo-Tello, C. M., Hodgkinson, S., Spitaleri, D. L. A., Petersen, T., Butler, E. G., Slee, M., McGuigan, C., McCombe, P. A., Granella, F., Cristiano, E., Prevost, J., Taylor, B. V., Sãnchez-Menoyo, J. L., Laureys, G., Van Hijfte, L., Vucic, S., MacDonell, R. A., Gray, O., Olascoaga, J., Deri, N., Fragoso, Y. D., Shaw, C., Kalincik, T. & on behalf of the MSBase Study Group, 14 Jun 2022, In: Neurology. 98, 24, p. e2401-e2412 12 p.
Research output: Contribution to journal › Article › Research › peer-review

24 Citations (Scopus)

Biomarkers to prevent disability in multiple sclerosis

Project Details

Keywords

Research output

Comparative effectiveness in multiple sclerosis: A methodological comparison

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study